A Pharmacovigilance Officer is dedicated to ensuring the ongoing safety of therapeutic products by systematically monitoring and evaluating adverse effects reported by patients and healthcare providers. Their role involves gathering detailed safety data, assessing causality, and identifying any potential risks that may arise during a product’s use in the general population. Through careful analysis of this information, they help detect new safety signals and contribute to updating risk-benefit assessments. Collaboration with regulatory bodies and internal teams is key to maintaining compliance with global safety standards and ensuring timely reporting of adverse events. They also play a proactive role in promoting a culture of safety by educating healthcare professionals and patients about reporting processes.
Pharmacovigilance Officers are responsible for preparing comprehensive safety documentation, including Periodic Safety Update Reports (PSURs) and Risk Management Plans (RMPs). They also develop and implement safety monitoring protocols and train staff on adverse event reporting requirements. Staying current with changing regulations and safety guidelines enables them to adapt processes effectively and maintain rigorous safety surveillance. Their work plays a vital role in protecting patient health by ensuring that any emerging risks are promptly identified and managed throughout the product’s lifecycle. By continuously enhancing safety monitoring systems, they help maintain public trust in healthcare products and contribute to safer therapeutic outcomes.
Title : Medical liver biopsy: Toward a personalized approach
Consolato M Sergi, Universities of Alberta and Ottawa, Canada
Title : Emerging formulation and delivery applications of vitamin E TPGS
Andreas M Papas, Antares Health Products, United States
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through design-inspired biotech- & biopharma-driven applications and upgraded business marketing to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia
Title : Mathematical modeling the disc diffusion test: Antibacterial activity of copper-doped SnO2
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Genetic keys and nano locks: Unlocking personalized medicine
Srividya Narayanan, Northeastern University, United States
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico